Target intelligence / Profile preview

Enteroendocrine cell (EEC)

Target
EEC
Molecular classification
Other
01

Overview

Enteroendocrine cells (EECs) are specialized sensory cells distributed throughout the intestinal epithelium that function as the primary nutrient sensors of the gastrointestinal tract (Gribble & Reimann, 2016, Annu Rev Physiol). They respond to luminal stimuli, such as glucose, fatty acids, and amino acids, by secreting a variety of peptide hormones including glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and cholecystokinin (CCK) (Adriaenssens et al., 2018, Front Endocrinol). These hormones are vital for regulating postprandial glucose levels, gastric emptying, and satiety. In metabolic diseases like type 2 diabetes and obesity, the secretory response of these cells is often blunted, making them a significant area of therapeutic interest (Beutler & O'Rahilly, 2022, The Enteroendocrine System). While EECs themselves are a cell population rather than a single molecular target, pharmacological agents often target specific receptors on their surface, such as GPR119, TGR5, or FFA1, to stimulate endogenous hormone release (Lauffer et al., 2009, J Biol Chem). Understanding the diversity and signaling pathways of EEC subtypes, such as L-cells and K-cells, is crucial for developing next-generation metabolic therapies.

Other names
Intestinal nutrient-sensing cellsGut endocrine cellsL-cellsK-cellsI-cellsEnterochromaffin cellsGastrointestinal endocrine cells
02

Mechanism of action

Activation of nutrient-sensing G protein-coupled receptors (GPCRs) on the cell surface to stimulate the endogenous release of metabolic hormones such as GLP-1 and PYY.

03

Biological functions

Nutrient sensingHormone secretionGlucose homeostasisAppetite regulationGastrointestinal motilitySignal transduction
04

Disease associations

Type 2 diabetesObesityIrritable bowel syndromeMalabsorptionInflammatory bowel disease
05

Safety considerations

Gastrointestinal distressNauseaVomitingPotential for mucosal hyperplasiaRapid gastric emptying
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Glucagon-like peptide-1 (GLP-1)Peptide YY (PYY)Gastric inhibitory polypeptide (GIP)Chromogranin ACholecystokinin (CCK)

Beyond the preview

Go deeper on Enteroendocrine cell (EEC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enteroendocrine cell (EEC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call